摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-溴苯基磺酰)-1H-吡咯 | 16851-84-6

中文名称
1-(4-溴苯基磺酰)-1H-吡咯
中文别名
1-(4-溴苯基磺酰基)-1H-吡咯
英文名称
1-((4-bromophenyl)sulfonyl)-1H-pyrrole
英文别名
1-(4-Bromophenylsulfonyl)-1H-pyrrole;1-(4-bromophenyl)sulfonylpyrrole
1-(4-溴苯基磺酰)-1H-吡咯化学式
CAS
16851-84-6
化学式
C10H8BrNO2S
mdl
——
分子量
286.149
InChiKey
WTLWGWZWPABAIF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    156-161
  • 沸点:
    409.9±47.0 °C(Predicted)
  • 密度:
    1.58±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    47.4
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    存储条件:室温、密封、干燥

SDS

SDS:15e5fc1abed19face4627ed6ffe43254
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-(4-Bromophenylsulfonyl)-1H-pyrrole
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1-(4-Bromophenylsulfonyl)-1H-pyrrole
CAS number: 16851-84-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H8BrNO2S
Molecular weight: 286.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    1-(4-溴苯基磺酰)-1H-吡咯 在 (4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate 、 palladium diacetate 、 potassium carbonateN,N-二异丙基乙胺 作用下, 以 甲醇甲苯乙腈 为溶剂, 反应 18.17h, 生成 4-甲磺酰基联苯
    参考文献:
    名称:
    通过磺酰基吡咯进行初级磺酰胺官能化:从不同的角度观察 N-Ts 键
    摘要:
    磺胺类药物在药物分子中很普遍,然而,通过 S-N 键裂解功能化磺胺类药物的方法很少。基于对 N-Ts 脱保护的重新评估,我们开发了磺酰吡咯作为磺酰胺功能化的关键。磺酰基吡咯参与可以通过化学、电化学或光化学途径进行的各种转化。
    DOI:
    10.1002/chem.202102748
  • 作为产物:
    描述:
    吡咯4-溴苯磺酰氯lithium hexamethyldisilazane 作用下, 以 四氢呋喃 为溶剂, 反应 20.0h, 以52%的产率得到1-(4-溴苯基磺酰)-1H-吡咯
    参考文献:
    名称:
    消除杂环正电子发射断层扫描放射性配体的铜介导的 18F-氟化
    摘要:
    用氟 18 (18F) 标记的分子用于正电子发射断层扫描,以可视化、表征和测量体内的生物过程。尽管最近在将 18F 掺入芳烃方面取得了进展,但开发通用且有效的方法来标记药物发现计划所需的放射性配体仍然是一项重大任务。这个完整的描述描述了杂环正电子发射断层扫描 (PET) 放射性配体的放射合成方法,使用铜介导的 18F 氟化芳基硼试剂与 18F 氟化物作为模型反应。该方法基于一项研究,该研究检查了药物开发中常用的杂环的存在如何影响代表性芳基硼试剂的 18F-氟化效率,以及超过 50 种(杂)芳基硼酸酯的标记。这组数据允许将这种去风险策略应用于七种结构复杂的药物相关含杂环分子的成功放射合成。
    DOI:
    10.1021/jacs.7b03131
点击查看最新优质反应信息

文献信息

  • Iron-Catalyzed Inexpensive and Practical Synthesis of N-Substituted Pyrroles in Water
    作者:Najmedin Azizi、Alireza Khajeh-Amiri、Hossein Ghafuri、Mohammad Bolourtchian、Mohammad Saidi
    DOI:10.1055/s-0029-1217799
    日期:2009.9
    An operationally simple, practical, and economical protocol for iron(III) chloride catalyzed Paal-Knorr pyrrole synthesis in water in good to excellent yields has been developed. Several N-substituted pyrroles are readily prepared from the reaction of 2,5-dimethoxytetrahydrofuran and aryl/alkyl, sulfonyl and acyl amines under very mild reaction conditions
    一种操作简便、实用且经济的实验方案已被开发,用于在相中以(III)化物为催化剂进行Paal-Knorr吡咯合成,产率良好至优异。在非常温和的反应条件下,多个N-取代吡咯可以方便地通过2,5-二甲氧基四氢呋喃与芳基/烷基、磺酰基和酰基胺的反应来制备。
  • ARYL SULFONAMIDES USEFUL FOR MODULATION OF THE PROGESTERONE RECEPTOR
    申请人:McComas Casey Cameron
    公开号:US20080221201A1
    公开(公告)日:2008-09-11
    In one embodiment, compounds of the following structure are described, wherein R 1 to R 7 are described herein. Also provided are methods for preparing these compounds and methods of contraception; treating or preventing fibroids; treating or preventing uterine leiomyomata; treating or preventing endometriosis, dysfunctional bleeding, and polycystic ovary syndrome; treating or preventing hormone-dependent carcinomas; providing hormone replacement therapy; stimulating food intake; synchronizing estrus; and treating cycle-related symptoms using the compounds described herein.
    在一个实施例中,描述了以下结构的化合物,其中R1到R7在此处描述。 还提供了制备这些化合物的方法以及避孕的方法;治疗或预防纤维瘤;治疗或预防子宫平滑肌瘤;治疗或预防子宫内膜异位症、功能性出血和多囊卵巢综合征;治疗或预防激素依赖性癌症;提供激素替代疗法;刺激食欲;同步发情;并使用此处描述的化合物治疗与周期相关的症状。
  • Synthesis of N-Sulfonyl- and N-Acylpyrroles via a Ring-Closing Metathesis/Dehydrogenation Tandem Reaction
    作者:Weiqiang Chen、Yin-Lin Zhang、Hui-Jing Li、Xiang Nan、Ying Liu、Yan-Chao Wu
    DOI:10.1055/s-0039-1690002
    日期:2019.10
    N-acylpyrroles were synthesized via olefin ring-closing metathesis of diallylamines and in situ oxidative aromatization in the presence of the ruthenium Grubbs catalyst and a suitable copper catalyst. In the presence of Cu(OTf)2 and CuBr2, the reaction afforded N-sulfonyl- and N-acylpyrroles, respectively, in one pot. Under an oxygen atmosphere, the reaction went smoothly without the need of hydroperoxide
    抽象的 N-磺酰基-和N-酰基吡咯是通过二烯丙基胺的烯烃闭环易位和在Grubbs催化剂和合适的催化剂的存在下原位氧化芳构化而合成的。在Cu(OTf)2和CuBr 2的存在下,反应在一锅中分别得到N-磺酰基-和N-酰基吡咯。在氧气气氛下,不需要氢过氧化物氧化剂即可使反应顺利进行。该方案具有许多优点,例如使用无害氧化剂和易于获得的起始原料,在一个锅中操作,并显示出广泛的底物范围。 N-磺酰基-和N-酰基吡咯是通过二烯丙基胺的烯烃闭环易位和在Grubbs催化剂和合适的催化剂的存在下原位氧化芳构化而合成的。在Cu(OTf)2和CuBr 2的存在下,反应在一锅中分别得到N-磺酰基-和N-酰基吡咯。在氧气气氛下,不需要氢过氧化物氧化剂即可使反应顺利进行。该方案具有许多优点,例如使用无害氧化剂和易于获得的起始原料,在一个锅中操作,并显示出广泛的底物范围。
  • New insights into the solubilization of Bodipy dyes
    作者:Song-Lin Niu、Gilles Ulrich、Pascal Retailleau、Jack Harrowfield、Raymond Ziessel
    DOI:10.1016/j.tetlet.2009.04.017
    日期:2009.7
    protection of sulfonate groups by pyrrole of indopyrrole appears efficient but the deprotection step does not offer viable routes. Conversion of the bromopyrene or iodo Bodipy compounds to sulfobetaine derivatives is feasible either by cross-coupling directly the ethynylsulfobetaine or by first cross-coupling 1-(N,N-dimethylamino)-prop-2-yne followed by quaternization of the dimethylamino residue with 1,3-propanesultone
    合成了具有各种取代基的几种Bodipy染料,这些取代基旨在改善溶性。在不同的合成策略中,通过吲哚吡咯吡咯保护磺酸盐基团似乎是有效的,但是脱保护步骤没有提供可行的途径。通过将乙炔基磺基甜菜碱直接交叉偶联或先将1-(N,N-二甲基基)-丙-2-炔进行交叉偶联,然后再将二甲基基残基季化,将化re或化的Bodipy化合物转化为磺基甜菜碱生物是可行的。 1,3-丙磺酸内酯。这些染料中的一些(Bodipy's和pyr)在中可适当溶解,并且在极性溶剂和中仍保持高荧光性。
  • Triflic acid controlled successive annelation of aromatic sulfonamides: an efficient one-pot synthesis of N-sulfonyl pyrroles, indoles and carbazoles
    作者:Mohammed Abid、Liliana Teixeira、Béla Török
    DOI:10.1016/j.tetlet.2007.04.021
    日期:2007.6
    A novel one-pot synthesis of N-substituted heterocycles via successive cyclization/annelation starting from primary sulfonamides is described. This process leads directly to N-sulfonyl pyrroles, indoles and carbazoles. The selection of appropriate reactant/triflic acid ratio successfully controls the formation of the desired product.
    描述了一种从伯磺酰胺开始通过连续环化/退火来合成 N-取代杂环的新型一锅法。该过程直接生成N-磺酰基吡咯吲哚咔唑。选择适当的反应物/三氟甲磺酸比率成功地控制了所需产物的形成。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫